Nuzenio

Compass Therapeutics Reports

Compass Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Compass Therapeutics (NASDAQ:CMPX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTCompass Therapeutics (NASDAQ:CMPX) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTCompass Therapeutics, Inc. Q2 2026 Financial Results: Balance Sheet, Losses & Key Highlights from CMPX 10-Q Filing - MinichartMinichart · Thu, 06 Aug 2026 23:02:00 GMTCompass Therapeutics Announces Q2 2026 Financial Results with Increased Net Loss and Operating Expenses - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:40:23 GMTCompass Therapeutics Q2 2026 earnings: Pipeline spending widens the net loss - TradingKeyTradingKey · Thu, 06 Aug 2026 12:23:02 GMTCompass Therapeutics, Inc. 2026: Revenue ($25.25M), Net income ($25.15M), EPS ($0.13) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:11:09 GMTCompass Therapeutics (NASDAQ: CMPX) details Q2 loss and BTC trial gains - Stock TitanStock Titan · Thu, 06 Aug 2026 12:01:31 GMTCompass Therapeut reports Q2 2026 net loss $25.2M, $180M cash runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:33:01 GMT

Timeline

Sat, 08 Aug 2026 05:48:57 GMTCompass Therapeutics (NASDAQ:CMPX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Sat, 08 Aug 2026 04:52:38 GMTCompass Therapeutics (NASDAQ:CMPX) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Thu, 06 Aug 2026 23:02:00 GMTCompass Therapeutics, Inc. Q2 2026 Financial Results: Balance Sheet, Losses & Key Highlights from CMPX 10-Q Filing - Minichart
Thu, 06 Aug 2026 17:40:23 GMTCompass Therapeutics Announces Q2 2026 Financial Results with Increased Net Loss and Operating Expenses - Kalkine Media
Thu, 06 Aug 2026 12:23:02 GMTCompass Therapeutics Q2 2026 earnings: Pipeline spending widens the net loss - TradingKey
Thu, 06 Aug 2026 12:11:09 GMTCompass Therapeutics, Inc. 2026: Revenue ($25.25M), Net income ($25.15M), EPS ($0.13) — 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Compass Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.